Acetonitrile

Acetonitrile (methyl cyanide) is produced primarily as a byproduct of the Sohio acrylonitrile process, in which propylene is catalytically oxidized with ammonia to produce acrylonitrile; acetonitrile is a coproduct recovered from the byproduct stream. [1] This production route means that acetonitrile availability is intimately linked to acrylonitrile production volumes. It is an exceptionally useful polar aprotic solvent — miscible with water and most organic solvents, high UV transparency, and compatible with reversed-phase HPLC — making it the standard solvent in high-performance liquid chromatography, mass spectrometry sample preparation, and pharmaceutical analysis worldwide. Annual global consumption for HPLC applications alone runs to hundreds of thousands of liters. Industrial applications include as a solvent for spinning synthetic fibers, as an extraction solvent in pharmaceutical manufacturing, and as an intermediate in pesticide and pharmaceutical synthesis. Acetonitrile gained public health attention in the 1990s when it was the solvent in several nail polish remover formulations; health concerns about cosmetic product poisonings prompted FDA to recommend its removal from consumer products. [2] In toxicology, acetonitrile is classified not as a direct poison but as a metabolic precursor to cyanide — it is oxidized by cytochrome P450 2E1 to produce cyanohydrin and ultimately hydrogen cyanide, which inhibits cytochrome c oxidase and blocks cellular respiration. [3]

Laboratory workers (chemists, biochemists, pharmaceutical analysts) using acetonitrile as an HPLC solvent or reaction solvent are the largest group of regular occupational users. Industrial workers in chemical synthesis and fiber spinning operations face higher-level inhalation exposures. Consumer exposure historically occurred from acetonitrile-containing nail polish removers. The compound is also a minor component of tobacco smoke.

Acetonitrile's toxicity stems from its slow conversion to cyanide in the body — the delayed onset of symptoms (6–12 hours after exposure) is a dangerous characteristic that can lead to underestimation of exposure severity. [3] At high concentrations or doses, symptoms include headache, nausea, dizziness, and ultimately metabolic acidosis and cellular asphyxia from cyanide inhibition of cytochrome c oxidase. Unconsciousness and death can follow significant acute overexposures. The NIOSH IDLH is 500 ppm, and the REL (TWA) is 40 ppm. Laboratory workers using acetonitrile daily over careers have lower but persistent inhalation exposure that warrants adequate ventilation.

Analytical chemistry laboratories are the primary exposure setting — HPLC analysts who handle liters of acetonitrile daily in research and pharmaceutical QC labs. Chemical plant workers where acetonitrile is produced or used industrially face higher exposure levels. Historical cases of severe poisoning occurred from accidental ingestion of acetonitrile-containing cosmetic products.

1. Analytical chemists should use HPLC-grade acetonitrile in well-ventilated fume hoods or chromatography enclosures; avoid working with open containers of acetonitrile in closed rooms. 2. Store large quantities in flammable-safe storage (acetonitrile is flammable, flashpoint 2°C). 3. Wear nitrile gloves when handling — don't allow skin contact with the liquid. 4. Industrial workers should have continuous air monitoring with LEL and NIOSH-based alarms. 5. Know the cyanide antidote protocol in your facility — hydroxocobalamin auto-injectors (Cyanokit) or sodium nitrite/sodium thiosulfate should be available.